203 related articles for article (PubMed ID: 16142322)
1. Proteasome inhibition improves fractionated radiation treatment against non-small cell lung cancer: an antioxidant connection.
Grimes KR; Daosukho C; Zhao Y; Meigooni A; St Clair W
Int J Oncol; 2005 Oct; 27(4):1047-52. PubMed ID: 16142322
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH
Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492
[TBL] [Abstract][Full Text] [Related]
3. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.
Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH
Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927
[TBL] [Abstract][Full Text] [Related]
4. Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection.
Dreger H; Westphal K; Weller A; Baumann G; Stangl V; Meiners S; Stangl K
Cardiovasc Res; 2009 Jul; 83(2):354-61. PubMed ID: 19351736
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB dependency of doxorubicin sensitivity in gastric cancer cells is determined by manganese superoxide dismutase expression.
Cho SJ; Park JW; Kang JS; Kim WH; Juhnn YS; Lee JS; Kim YH; Ko YS; Nam SY; Lee BL
Cancer Sci; 2008 Jun; 99(6):1117-24. PubMed ID: 18384434
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.
Russo SM; Tepper JE; Baldwin AS; Liu R; Adams J; Elliott P; Cusack JC
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):183-93. PubMed ID: 11316563
[TBL] [Abstract][Full Text] [Related]
7. The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Pajonk F; Himmelsbach J; Riess K; Sommer A; McBride WH
Cancer Res; 2002 Sep; 62(18):5230-5. PubMed ID: 12234989
[TBL] [Abstract][Full Text] [Related]
8. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
9. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
Kashyap T; Argueta C; Aboukameel A; Unger TJ; Klebanov B; Mohammad RM; Muqbil I; Azmi AS; Drolen C; Senapedis W; Lee M; Kauffman M; Shacham S; Landesman Y
Oncotarget; 2016 Nov; 7(48):78883-78895. PubMed ID: 27713151
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-κB and DNA double-strand break repair by DMAPT sensitizes non-small-cell lung cancers to X-rays.
Estabrook NC; Chin-Sinex H; Borgmann AJ; Dhaemers RM; Shapiro RH; Gilley D; Huda N; Crooks P; Sweeney C; Mendonca MS
Free Radic Biol Med; 2011 Dec; 51(12):2249-58. PubMed ID: 22019440
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors up-regulate haem oxygenase-1 gene expression: requirement of p38 MAPK (mitogen-activated protein kinase) activation but not of NF-kappaB (nuclear factor kappaB) inhibition.
Wu WT; Chi KH; Ho FM; Tsao WC; Lin WW
Biochem J; 2004 May; 379(Pt 3):587-93. PubMed ID: 14731112
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity.
Park IH; Kim JY; Choi JY; Han JY
Invest New Drugs; 2011 Oct; 29(5):883-90. PubMed ID: 20467885
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.
Lövborg H; Oberg F; Rickardson L; Gullbo J; Nygren P; Larsson R
Int J Cancer; 2006 Mar; 118(6):1577-80. PubMed ID: 16206267
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB inhibition through proteasome inhibition or IKKbeta blockade increases the susceptibility of melanoma cells to cytostatic treatment through distinct pathways.
Amschler K; Schön MP; Pletz N; Wallbrecht K; Erpenbeck L; Schön M
J Invest Dermatol; 2010 Apr; 130(4):1073-86. PubMed ID: 19940859
[TBL] [Abstract][Full Text] [Related]
15. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
17. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha.
Place RF; Noonan EJ; Giardina C
Biochem Pharmacol; 2005 Aug; 70(3):394-406. PubMed ID: 15950952
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer.
Son B; Jun SY; Seo H; Youn H; Yang HJ; Kim W; Kim HK; Kang C; Youn B
Sci Rep; 2016 Feb; 6():21986. PubMed ID: 26906215
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
Takigawa N; Vaziri SA; Grabowski DR; Chikamori K; Rybicki LR; Bukowski RM; Ganapathi MK; Ganapathi R; Mekhail T
Anticancer Res; 2006; 26(3A):1869-76. PubMed ID: 16827119
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition.
Pajonk F; Pajonk K; McBride WH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1025-32. PubMed ID: 10863075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
